SCHEMBL25453056

SCHEMBL25453056

Cc1cc2c(cc1F)C(=O)N(C)C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 2/20 0.37
CRBN Q96SW2 2/20 0.37
UGCG Q16739 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LRRK2 Q5S007 4/20 0.35
BRD4 O60885 1/20 0.34
DRD3 P35462 1/20 0.34
PRF1 P14222 3/20 0.33
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
CYP2C19 P33261 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRB2 P47870 2/20 0.33
ABL1 P00519 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2C9 P11712 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25453057 0.85 DDB1 (0.40) DDB1CRBNUGCGMEN1KMT2A
SCHEMBL5986824 0.83 MEN1 (0.55) DDB1CRBNMEN1KMT2A
SCHEMBL26767589 0.82 UGCG (0.34) UGCGMEN1KMT2ABRD4GABRA1
SCHEMBL26767592 0.80 ESR1 (0.40) CRBNUGCGGABRA1GABRG2GABRB3
SCHEMBL25457841 0.79 MEN1 (0.40) DDB1CRBNMEN1KMT2ALRRK2
SCHEMBL21610984 0.79 LRRK2 (0.46) DDB1CRBNMEN1KMT2ALRRK2
SCHEMBL15727774 0.77 BRD4 (0.40) DDB1CRBNUGCGMEN1KMT2A
SCHEMBL26460455 0.77 UGCG (0.38) DDB1CRBNUGCGMEN1KMT2A
SCHEMBL26768102 0.77 MEN1 (0.43) UGCGMEN1KMT2ALRRK2PRF1
SCHEMBL12559535 0.76 MEN1 (0.55) DDB1CRBNMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024096753-A1 NEK7 DEGRADERS AND METHODS OF USE THEREOF CAPTOR THERAPEUTICS S.A. (PL) 2024-05-10 WO disclosed
WO-2024094819-A1 NEK7 DEGRADERS AND METHODS OF USE THEREOF CAPTOR THERAPEUTICS S.A. (PL) 2024-05-10 WO disclosed
WO-2023081845-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 WO disclosed